353 related articles for article (PubMed ID: 29114070)
1. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
Wan L; Yu W; Shen E; Sun W; Liu Y; Kong J; Wu Y; Han F; Zhang L; Yu T; Zhou Y; Xie S; Xu E; Zhang H; Lai M
Gut; 2019 Jan; 68(1):118-129. PubMed ID: 29114070
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
Si Z; Yu L; Jing H; Wu L; Wang X
J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
[TBL] [Abstract][Full Text] [Related]
3. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R
J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731
[TBL] [Abstract][Full Text] [Related]
4. The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells.
Lin JC; Lee YC; Liang YC; Fann YC; Johnson KR; Lin YJ
Sci Rep; 2017 Mar; 7():44204. PubMed ID: 28276498
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6.
Kong J; Sun W; Li C; Wan L; Wang S; Wu Y; Xu E; Zhang H; Lai M
Cancer Lett; 2016 Oct; 380(2):476-484. PubMed ID: 27443606
[TBL] [Abstract][Full Text] [Related]
6. Genetic compensation response could exist in colorectal cancer: UPF3A upregulates the oncogenic homologue gene SRSF3 expression corresponding to SRSF6 to promote colorectal cancer metastasis.
Xu W; Ou W; Feng Y; Xu Q; Yang Y; Cui L; Du P
J Gastroenterol Hepatol; 2023 Apr; 38(4):634-647. PubMed ID: 36807382
[TBL] [Abstract][Full Text] [Related]
7. SRSF6 regulates alternative splicing of genes involved in DNA damage response and DNA repair in HeLa cells.
Yang X; Zhan P; Feng S; Ji H; Tian W; Wang M; Cheng C; Song B
Oncol Rep; 2020 Nov; 44(5):1851-1862. PubMed ID: 32901876
[TBL] [Abstract][Full Text] [Related]
8. The RNA-binding profile of the splicing factor SRSF6 in immortalized human pancreatic β-cells.
Alvelos MI; Brüggemann M; Sutandy FR; Juan-Mateu J; Colli ML; Busch A; Lopes M; Castela Â; Aartsma-Rus A; König J; Zarnack K; Eizirik DL
Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376132
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68.
Wang X; Yu H; Sun W; Kong J; Zhang L; Tang J; Wang J; Xu E; Lai M; Zhang H
Mol Cancer; 2018 Jul; 17(1):110. PubMed ID: 30064438
[TBL] [Abstract][Full Text] [Related]
10. RBM4-Nova1-SRSF6 splicing cascade modulates the development of brown adipocytes.
Lin JC; Chi YL; Peng HY; Lu YH
Biochim Biophys Acta; 2016 Nov; 1859(11):1368-1379. PubMed ID: 27535496
[TBL] [Abstract][Full Text] [Related]
11. Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer.
Park WC; Kim HR; Kang DB; Ryu JS; Choi KH; Lee GO; Yun KJ; Kim KY; Park R; Yoon KH; Cho JH; Lee YJ; Chae SC; Park MC; Park DS
BMC Cancer; 2016 Jun; 16():358. PubMed ID: 27282379
[TBL] [Abstract][Full Text] [Related]
12. Zinc-induced modulation of SRSF6 activity alters Bim splicing to promote generation of the most potent apoptotic isoform BimS.
Hara H; Takeda T; Yamamoto N; Furuya K; Hirose K; Kamiya T; Adachi T
FEBS J; 2013 Jul; 280(14):3313-27. PubMed ID: 23648111
[TBL] [Abstract][Full Text] [Related]
13. Splicing factor SRSF6 promotes hyperplasia of sensitized skin.
Jensen MA; Wilkinson JE; Krainer AR
Nat Struct Mol Biol; 2014 Feb; 21(2):189-97. PubMed ID: 24440982
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.
Kouyama Y; Masuda T; Fujii A; Ogawa Y; Sato K; Tobo T; Wakiyama H; Yoshikawa Y; Noda M; Tsuruda Y; Kuroda Y; Eguchi H; Ishida F; Kudo SE; Mimori K
Cancer Sci; 2019 Oct; 110(10):3132-3144. PubMed ID: 31390121
[TBL] [Abstract][Full Text] [Related]
15. SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis.
Xu T; Li X; Zhao W; Wang X; Jin L; Feng Z; Li H; Zhang M; Tian Y; Hu G; Yue Y; Dai X; Shan C; Zhang W; Zhang C; Zhang Y
J Exp Clin Cancer Res; 2024 Apr; 43(1):126. PubMed ID: 38671459
[TBL] [Abstract][Full Text] [Related]
16. Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA.
Choi N; Liu Y; Oh J; Ha J; Ghigna C; Zheng X; Shen H
BMB Rep; 2021 Mar; 54(3):176-181. PubMed ID: 33050987
[TBL] [Abstract][Full Text] [Related]
17. Poison cassette exon splicing of SRSF6 regulates nuclear speckle dispersal and the response to hypoxia.
de Oliveira Freitas Machado C; Schafranek M; Brüggemann M; Hernández Cañás MC; Keller M; Di Liddo A; Brezski A; Blümel N; Arnold B; Bremm A; Wittig I; Jaé N; McNicoll F; Dimmeler S; Zarnack K; Müller-McNicoll M
Nucleic Acids Res; 2023 Jan; 51(2):870-890. PubMed ID: 36620874
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma.
Liu W; Li D; Lu T; Zhang H; Chen Z; Ruan Q; Zheng Z; Chen L; Guo J
J Biol Chem; 2023 Feb; 299(2):102876. PubMed ID: 36623729
[TBL] [Abstract][Full Text] [Related]
19. Targeting Splicing Factor SRSF6 for Cancer Therapy.
She W; Shao J; Jia R
Front Cell Dev Biol; 2021; 9():780023. PubMed ID: 34917618
[TBL] [Abstract][Full Text] [Related]
20. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]